Controlled drug delivery in tissue engineering.
By M. Biondi, F. Ungaro, F. Quaglia, Paolo Antonio Netti. Advanced Drug Delivery Reviews, 2008
389 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering
View Paper: https://www.semanticscholar.org/paper/891afdaa4505b684c85ac22d6454f0d80df47904
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
Citations in the corpus
- Bone tissue engineering: A review in bone biomimetics and drug delivery strategies (2009, background): “Therefore, many of the strategies investigated (such as bolus administration) is not effective due to rapid diffusion from the target site and deactivation/digestion by ubiquitous enzymes.(228) Ideally, the presentation of bioactive molecules or drugs must be finely tuned to dynamically match the ph”
- A review of bacterial cellulose‐based drug delivery systems: their biochemistry, current approaches and future prospects (2014, background): “For example, therapeutic proteins such as growth factors and signalling molecules have both been delivered in this way.([104]) BC is an excellent candidate for TES as evidenced by the results of a study in which BC nanofibres with appropriate porosity were investigated for their application as bioco”
- Drug Release Kinetics and Transport Mechanisms of Non-degradable and Degradable Polymeric Delivery Systems (2010, background): “PEVA-based devices are designed to release drug compounds slowly over a relatively long period of time [27].”